Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives-Reference-Cited by-同舟云学术

Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives

Published:2023-08 Issue: Volume:Volume 16 Page:2135-2142
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Mager Layna,Gardeen Samantha,Carr David R,Shahwan Kathryn T

Publisher

Informa UK Limited

Subject

Dermatology

Reference43 articles.

1. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

2. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study

3. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death

4. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death

5. European Medicines Agency. Libtayo (cemiplimab): EU public assessment report [homepage on the internet]; 2019. Available from: http://www.ema.europa.eu. Accessed March 16, 2023.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cemiplimab-Induced Hyperosmolar Hyperglycemic State With Concurrent Diabetic Ketoacidosis in a Patient Receiving Treatment for Cutaneous Squamous Cell Carcinoma;Cureus;2024-05-18

2. Exploring Costimulatory Blockade-Based Immunologic Strategies in Transplantation: Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?;Journal of Personalized Medicine;2024-03-20

3. A Novel Intersection - Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient with Advanced Cutaneous Squamous Cell Carcinoma: a Case Report;2024-01-19

4. PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment;Frontiers in Immunology;2023-12-01